Pneumococcal modification of host sugars: a major contributor to colonization of the human airway?

S J King1

  • 1Center of Microbial Pathogenesis, Nationwide Children's Hospital, 700 Children's Drive, Columbus, OH 43205, USA. Samantha.King@nationwidechildrens.org

Insights

Streptococcus pneumoniae uses glycosidases to modify airway sugars, aiding its colonization. These enzymes provide nutrients, promote biofilm, and enhance bacterial adherence, crucial for disease development.

Area of Science:

  • Microbiology
  • Biochemistry
  • Pathogenesis

Background:

  • Streptococcus pneumoniae colonization is a key step in disease development.
  • Mechanisms of S. pneumoniae airway colonization are not fully understood.
  • S. pneumoniae possesses glycosidases that modify host glycans.

Purpose of the Study:

  • To review the role of S. pneumoniae glycosidases in host sugar modification.
  • To elucidate the functional effects of these modifications during colonization.

Main Methods:

  • Literature review of experimental evidence.
  • Analysis of in vitro and in vivo studies on pneumococcal glycosidases.

Main Results:

  • S. pneumoniae glycosidases modify N-linked glycans, O-linked glycans, and glycosaminoglycans.
  • These enzymes contribute to S. pneumoniae in vivo colonization.
  • In vitro data suggest roles in nutrient acquisition, biofilm formation, inter-bacterial competition, and adherence.

Conclusions:

  • Pneumococcal glycosidases play a significant role in airway colonization.
  • Modification of host sugars by S. pneumoniae is a key strategy for pathogenesis.

Related Concept Videos

Colonisation of Pathogens01:25

Colonisation of Pathogens

Pathogen colonization of host tissues is a critical step in the development of infectious diseases. Various pathogenic microorganisms, including bacteria, fungi, viruses, and protozoa, have evolved complex strategies to attach to, invade, and persist within host environments. These mechanisms enable pathogens to establish infections, evade immune responses, and resist antimicrobial treatments.Attachment to Host CellsIn bacteria, colonization typically begins with adherence to host epithelial...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps: